Kit Rapid Test BD Veritor™ System Antigen Detection SARS-CoV-2 / Influenza A + B Direct Anterior Nasal Swab Sample 30 Tests by BD ID 256088

188-1-6088
      
Stock Est. Shipping Date: 12th June 2025

Kit Rapid Test BD Veritor™ System Antigen Detection SARS-CoV-2 / Influenza A + B Direct Anterior Nasal Swab Sample 30 Tests
Sold by: KT OF 30

 Reviews
Better together

  • Total: $0.00

Rally #188-1-6088
BD #256088
BD Veritor™ Plus System SARS-CoV-2 & Flu A+B Kit (30 Test/KT)

Respiratory Test Kit, SARS-COV-2/FLU A+B, Rapid Chromatographic Digital Immunoassay, Anterior Nasal Swab, Rx Only

Features
  • May help reduce manual test processing errors with its easy operation and single-button functionality
  • Displays easy-to-read digital results for COVID-19 and Flu A+B in 15 minutes
  • Provides clear, objective results by correcting for nonspecific binding and detecting positives not recognized by the unaided eye
  • Adapts easily to your workflow by offering 2 operational modes: Walk Away and Analyze Now
  • Captures or downloads the lot number, patient/specimen ID, operator ID, and test records using the BD Veritor™ InfoWiFi module
The BD Veritor™ System for Rapid Detection of SARS-CoV-2 & Flu A+B is a rapid chromatographic digital immunoassay intended for the in vitro, simultaneous qualitative detection and differentiation of SARS-CoV-2 nucleocapsid antigen and/or influenza A and B nucleoprotein antigens directly from anterior nasal swab samples taken from individuals who are suspected of a viral respiratory infection consistent with COVID-19 by a healthcare provider, within the first six days of symptom onset.

This test is authorized for use at the Point of Care (POC), i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation.

This test is not intended to detect influenza C antigens. Results are for the simultaneous identification of SARS-CoV-2 nucleocapsid protein and Influenza A and B viral nucleoproteins.

Negative results should be treated as presumptive, do not rule out either Influenza or SARS-CoV-2, and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions.

Important Note:
  • Product is non-returnable; please make sure it is the right product before ordering.
  • If put into refrigeration, do not freeze.
  • For in vitro diagnostic use.
  • The test kit is intended for use with the analyzer.
  • For use under an Emergency Use Authorization (EUA) only.
  • For more information on this product's EUA, please go to the EUA section below.
For the State of California:
Warning: This product can expose you to chemicals known to the State of California to cause cancer. For more information, go to www.P65Warnings.ca.gov.

×
Rally #188-1-6088
Manufacturer #256088
GTIN00382902560883
BrandBD Veritor™ System
ManufacturerBD
Country of OriginUnknown
ApplicationRespiratory Test Kit
For Use WithFor use with the BD Veritor™ Plus Analyzer running Firmware version 5.50 or later
Number of Tests30 Tests
Reading TypeMachine Read
Sample TypeNasal Swab Sample
SpecialtyImmunoassay
Test FormatTest Device Format
Test Kit TypeRapid
Test MethodChromatographic Digital Immunoassay
Test NameSARS-CoV-2 / Influenza A + B
Test TypeAntigen Detection
Time to Results15 Minute Results
UNSPSC Code41116020
Storage Temperature2-30 °C (Do not Freeze)
Shelf Life (Days)485

Type PPA NPA Results In
SARS-CoV-2 86.7%
(95% CI, 75.8%-93.1%)
99.5%
(95% CI, 97.4%-99.9%)
15 minutes
Influenza A 82.7%
(95% CI, 74.9%-88.5%)
97.5%
(95% CI, 95.7%-98.5%)
15 minutes
Influenza B 80.7%
(95% CI, 70.3%-88.1%)
98.2%
(95% CI, 95.7%-99.3%)
15 minutes

PPA = positive percent agreement
NPA = negative percent agreement




No recommended products at the moment.